Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial
Titel:
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial
Auteur:
Soulières, Denis Faivre, Sandrine Mesía, Ricard Remenár, Éva Li, Shau-Hsuan Karpenko, Andrey Dechaphunkul, Arunee Ochsenreither, Sebastian Kiss, Laura Anna Lin, Jin-Ching Nagarkar, Raj Tamás, László Kim, Sung-Bae Erfán, Jozsef Alyasova, Anna Kasper, Stefan Barone, Carlo Turri, Sabine Chakravartty, Arunava Chol, Marie Aimone, Paola Hirawat, Samit Licitra, Lisa